MedPath

Effectiveness of vapocoolant spray versus lidocaine spray on vascular needle pai

Phase 3
Recruiting
Conditions
Venous access pain.
Pain, not elsewhere classified
Registration Number
IRCT20180826040868N1
Lead Sponsor
Bojnourd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
45
Inclusion Criteria

GCS 15
Ability to speak and understand Farsi or having Persian language translator
Not have pacemaker
Not have Known cardiac disease
Start hemodialysis at least 3 months ago
Not have Known reaction to lidocaine Products
Not have damaged skin
Not analgesic use in the last 24 hours
Not use of the cream or products lidocaine in the past
Hemodialysis via arteriovenous fistula
Not anti arrhythmic medications use (especially Class 3 for example Amiodarone)
Perform dialysis three times a week
age more than 18
age less than 80

Exclusion Criteria

Skin reaction or abnormal response in arteriovenous fistula site
Absence to perform hemodialysis
Failure in vascular access by first try at any of the stages

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain score. Timepoint: At the beginning of study, two days after, two weeks after the first intervention, four weeks after the first intervention and six weeks after the first intervention. Method of measurement: Numerical Rating Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath